Kynurenine metabolites were analyzed with the modified method of Virág and Wang [22, 23]. The standard compounds (tryptophan (PHR1176), L-kynurenine (K8625), kynurenic acid (K3375), and quinolinic acid (P63204)) were purchased from Sigma Aldrich (USA). The colon and brain tissues were homogenized using a bullet blender (Next Advance Inc.) with a D.W./MeOH/ACN (1:2:2). The homogenized tissue and blood plasma was mixed with trifluoroacetic acid and centrifuged at 20,000 ×g for 15 min. The supernatant lyophilized using a vacuum-tray freeze dryer (Operon). Powdered extract was dissolved with MeOH/ACN (1:1) and centrifuged at 20,000 ×g for 15 min. The supernatants were injected into an ultraperformance liquid chromatography/quadrupole time-of-flight tandem mass spectrometry system (UPLC-Q-TOF-MS, Vion, Waters Corp., USA). The extracted samples were separated on the Acquity UPLC BEH C18 Column (2.1 mm × 100 mm, 1.7 μm; Waters Corp.) equilibrated with water: acetonitrile (ACN) containing 0.1% formic acid. Elution was carried out at a flow rate of 0.35 ml/min for 12 min. Mass spectrometric detection was conducted by multiple reaction monitoring (MRM) with an electrospray ionization (ESI) source in the positive mode. The LC/MS conditions were as follows: ramp collision energy, 20–45V; oven temperature, 40°C; capillary voltage, 3kV; and mass range, 50–1500. The MRM conditions for the analytes are shown in Table 1.
Multiple reaction monitoring (MRM) conditions in the positive ESI mode.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.